4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-038977
COO and Secretary sold 10,000 shares at an average $64.55 ($645,500)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuth Alexander O. COO and Secretary | 2021-06-04 | Sale | −5,660 | $64.35 | $364,198 | 505,922 | I: show line 1 in the form |
| Schuth Alexander O. COO and Secretary | 2021-06-04 | Sale | −4,340 | $64.82 | $281,301 | 501,582 | I: show line 2 in the form |
| Open-market sales · 10,000 sh · avg $64.55 · $645,500 | |||||||
Loading xslF345X03/doc4.xml…